| Cordes, Ulrik (Biocartis 201309– CCO before Thermo Fisher + Dako A/S + Pharmacia Biotech A/S) |
Chief Commercial Officer (CCO) |
Biocartis (Group) |
Switzerland |
| Cornaglia, Matteo (Nagi Bioscience 202203 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nagi Bioscience S.A. |
Switzerland |
| Cornall, Jim (Inova Software 202205– Editor-in-Chief at Labiotech.eu formerly Editor at DairyReporter) |
Editor / Publisher |
Inova Software (Group) |
Germany |
| Cornett, Shannon (Bruker 201305 Applications Developm Manager) |
Research & Development Manager |
Bruker (Group) |
United States (USA) |
| Corr, David (EKF Diagnostics 201307– CTO before Head of RnD) |
Chief Technology/Technical Officer (CTO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Corr, Peter B. (Celtic Therapeutics 2007 Managing General Partner + Co-Founder) |
General Partner (venture partner) |
Auven Therapeutics (Group) |
United States (USA) |
| Corriveau, Jacques (AstraZeneca 201711– General Manager North America at Definiens) |
General Manager (management) |
AstraZeneca (Group) |
United States (USA) |
| Corsico, Christopher (Boehringer 201708 CMO) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Corsini, Lorenzo (PhagoMed 201910 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BioNTech (Group) |
Austria |
| Cortese, Riccardo (Nouscom 201605 CEO + Co-Founder before Okairos CEO + co-founder) |
Chief Executive Officer (CEO) |
Nouscom (Group) |
Switzerland |
| Corvaïa, Nathalie (Pierre Fabre 201404 Managing Director of Center of Immunology Pierre Fabre) |
Managing Director |
Pierre Fabre (Group) |
France |
| Coscia, Verena (Helmholtz 202308 Team Lead CorpComms + Press Officer at Helmholtz Munich) |
Public Relations Manager / Investor Relations Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Cospedal, Rosario (Zeltia 201211 CEO of Genomica S.A.U.) |
Chief Executive Officer (CEO) |
PharmaMar (Group) |
Spain (España) |
| Cossins, Aimee (Biosynth Carbosynth 202209 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Biosynth (since 9/22) (Group) |
Switzerland |
| Costantin, James (Nanion 201807 Director Customer Relations located at US West Coast Office) |
Sales Manager / Marketing Manager |
Nanion (Group) |
United States (USA) |
| Costantini, Dominique (OSE Pharma 201504 CEO + Co-founder + former CEO + Co-founder of BioAlliance Pharma in 1997) |
Chief Executive Officer (CEO) |
OSE Immunotherapeutics (Group) |
France |
| Costard, Jano (Germany (govt) 202306 Challenge Officer at SPRIND) |
n. a. |
Germany (govt) |
Germany |
| Cotte, Yann (Nanolive 201602 Managing Director) |
Managing Director |
Nanolive S.A. |
Switzerland |
| Cottier, Gilles (Sigma-Aldrich 201004 President SAFC) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Cottier, Gilles (Sigma-Aldrich 201504 EVP + President SAFC Commercial) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Cottier, Kaspar (Creoptix 201912– CTO + Founder) |
Chief Technology/Technical Officer (CTO) |
Spectris (Group) |
Switzerland |
| Cottrell, Steve (Maetrics 202009 President) |
President/Director/Head Business Group/Unit/Division |
Regulatory and Quality Solutions (R&G) (Group) |
United States (USA) |
| Couch, Gregory (Radimetrics 2009– CEO + Founder) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Canada |
| Coucke, Marc (Alychlo before Omega Pharma 1987– CEO + Founder) |
Chief Executive Officer (CEO) |
Alychlo (family office of Marc Coucke) |
|
| Coughlin, Robert K. (Massachusetts Biotech Council MBC 200904 President + CEO) |
Chief Executive Officer (CEO) |
Massachusetts Biotechnology Council (MassBio / MBC) |
United States (USA) |
| Coukos, George (Univ Lausanne 201601 Prof + Director of Ludwig Institute for Cancer Research) |
Professor |
University of Lausanne (UNIL) |
Switzerland |
| Coulter, Bianca (Coulter Partners 201711 CEO) |
Chief Executive Officer (CEO) |
Coulter Partners (The Coulter Partnership Ltd.) |
United Kingdom (GB) |
| Courtine, Grégoire (EPFL + CHUV 201604 + G-Therapeutics 201604 CSO + Co-Founder) |
Professor |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
| Coutanceau, Emmanuelle (Novo Group 201705 Novo Seeds before Auriga Partners) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Coutet, Matthieu (Advent France Biotechnology 201704 Managing Partner before Inserm Transfert) |
Managing Partner (investment firm) |
AdBio Partners (Group) |
France |
| Couttie, John (Peak Scientific 201310 General Manager Americas) |
General Manager (management) |
Peak Scientific (Group) |
United States (USA) |
| Cowan, Chad (Clade Therapeutics 202111 CEO + Co-Founder before Sana Biotechnology + CRISPR Therapeutics) |
Chief Executive Officer (CEO) |
Clade Therapeutics Inc. |
United States (USA) |
| Cowan, David (Univ London 1990– Professor + Director Drug Control Centre King’s College) |
Professor |
University of London |
United Kingdom (GB) |
| Cowling, Didier (Kuros 200807 CEO) |
Chief Executive Officer (CEO) |
Kuros (Group) |
Switzerland |
| Cox, John G. (Repertoire Immune Medicines 202104 CEO formerly Bioverativ 201801 CEO) |
Chief Executive Officer (CEO) |
Repertoire Immune Medicines (Group) |
United States (USA) |
| Cox, Jürgen (Max Planck 200705 MPI for Biochemistry) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Cox, Russel J. (Russ) (Epirium Bio 201912 CEO before Vital Therapies + Jazz Pharmaceuticals + Ipsen + Genentech) |
Chief Executive Officer (CEO) |
Epirium Bio Inc. |
United States (USA) |
| Cox, Steve |
n. a. |
Commerzbank (Group) |
Germany |
| Crabtree, Lucinda (MorphoSys 202307c– CFO before Autolus + Woodford Investment + Panmure Gordon + Goldman Sachs) |
Chief Financial Officer (CFO) |
MorphoSys (Group) |
Germany |
| Craft, Noah (Science 37 201703 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Science 37 Inc. |
United States (USA) |
| Craig, Frank F. (Sphere Fluidics 201711 CEO) |
Chief Executive Officer (CEO) |
Sphere Fluidics (Group) |
United Kingdom (GB) |
| Cramer, Patrick (LMU 201201 Professor + since 2004 Director of LMU Gene Center Munich) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Crameri, Melya Hughes (Ventac Partners 201912 Partner + Co-Founder) |
Partner (venture partner) |
Ventac Partners (Group) |
United States (USA) |
| Cravens, Aaron (Revel Pharmaceuticals 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Revel Pharmaceuticals (US) |
United States (USA) |
| Crawford, Bill (Roche 201112 Director of Marketing, Discovery at Ventana) |
Sales Manager / Marketing Manager |
Roche (Group) |
United States (USA) |
| Creasey, Theresa S. (Sigma-Aldrich 201411 VP Diagnostics + Testing of Applied Business Unit) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Creel, Jennifer (Jenn) (ADC Therapeutics 202004– CFO before Celgene + Watson Pharmaceuticals + Pfizer) |
Chief Financial Officer (CFO) |
ADC Therapeutics (Group) |
Switzerland |
| Cresswell, Warren (Nestlé 201707 General Manager + Head of Prometheus Diagnostics + CEO of MDP) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
United States (USA) |
| Cronet, Philippe (Wacker 202201 General Manager at Wacker Biotech US Inc) |
General Manager (management) |
Wacker (Group) |
United States (USA) |
| Crook, Jayne (Instinctif Partners 201603) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
| Crooke, Stanley T. (Isis Pharmaceuticals 200604 CEO) |
Chief Executive Officer (CEO) |
Ionis Pharmaceuticals (Group) |
United States (USA) |
| Crowe, Joanne (MorphoSys AbD –200603– Head Sales + Marketing) |
Sales Manager / Marketing Manager |
Bio-Rad (Group) |
Germany |
| Crowley, Bill (BioFi 202206– CFO + Chairman) |
Chief Financial Officer (CFO) |
BioFi AG |
Switzerland |
| Crowley, Erin (Q Laboratories 201802 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Q Laboratories Inc. |
United States (USA) |
| Crutchfield, Brad (Qiagen 201506–2016 SVP before Illumina + NanoString + Bio-Rad STEPPED DOWN 2016) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Netherlands |
| Ctortecka, Bernd (Max Planck 200908 Patent + License Manager Max Planck Innovation GmbH) |
IP Manager |
Max Planck Society for the Advancement of Science |
Germany |
| Cullen, Archie (Solvias 202203– CEO before Lonza + MilliporeSigma + BioReliance + Sigma-Aldrich + JRH Biosciences) |
Sales Manager / Marketing Manager |
Solvias (Group) |
Switzerland |
| Cullmann, Hans (Comicon GmbH 201101 Managing Director + Founder + 45% Owner) |
Managing Director |
Endress+Hauser (Group) |
Germany |
| Culp, H. Lawrence, Jr. (Danaher 2001–201502 CEO RETIRED 3/15) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Cummings, Sandra (PHC 202006 VP of Sales + Marketing at Epredia) |
Sales Manager / Marketing Manager |
PHC (Group) |
United States (USA) |
| Cunha, Fernando (AB2 Bio 201602 CFO) |
Chief Financial Officer (CFO) |
AB2 Bio S.A. |
Switzerland |
| Cunningham, Craig (Maine Manufacturing 2007– Founder + VP Engineering + Development) |
Research & Development Manager |
GVS (IT) (Group) |
United States (USA) |
| Cunningham, Darren (Mysthera Therapeutics 202308 CEO + Co-Founder before Inflection Biosciences + Amarin) |
Chief Executive Officer (CEO) |
Mysthera Therapeutics AG |
Switzerland |
| Cunningham, David (Royal Marsden Hospital 200909 Head Gastrointestinal Unit) |
Professor |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Curran, Michael A. (Immunogenesis 202003 Founder + MD Anderson Cancer Center Assoc Prof) |
Company Founder |
Immunogenesis Inc. |
United States (USA) |
| Currie, Ed (SIRS-Lab 200902– Executive VP Corp Development before Kuros BioSurgery before Lilly + Roche + IBM) |
Business Development Manager / Strategy Manager |
Endress+Hauser (Group) |
Germany |
| Curtin, Francois (Geneuro 201207 CEO) |
Chief Executive Officer (CEO) |
GeNeuro S.A. (Euronext Paris: GNRO) |
Switzerland |
| Curtis, Andrew (NMS Group 202208– Chief Strategy Officer before Artelus + GNS Healthcare + SUDA Pharma + Affimed) |
Business Development Manager / Strategy Manager |
NMS Group (Group) |
Italy |
| Curtis, Michael (Cadent Therapeutics 201811 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
United States (USA) |
| Curvers, Simon (Direvo 201101– Director R&D before at Direvo since 200711 + AC Biotech 200101–200905 Managing Director) |
Research & Development Manager |
Direvo Industrial Biotechnology (Group) |
Germany |
| Cuss, Francis (BMS 201410 EVP + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Cuypers, Heinrich (BioCon Valley 201105 Senior Project Manager) |
n. a. |
BioCon Valley GmbH |
Germany |
| Cymbler, Harry (Hot Cherry PR 202104 Founder) |
Public Relations Manager / Investor Relations Manager |
Hot Cherry PR – Harry Cymbler |
United Kingdom (GB) |
| Czeloth, Niklas (Boehringer 202311 Executive Director + Investment Manager at BIVF) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Czerepak, Elizabeth A. (Isarna Therapeutics 201404– CFO/CBO based in US before Bear Stearns Health Innoventures) |
Chief Financial Officer (CFO) |
Bear Stearns (Group) |
United States (USA) |
| Czerney, Peter (Dyomics 200301 Managing Director + Founder) |
Managing Director |
Dyomics GmbH |
Germany |
| da Silva, Nino (BC Platforms 201912 EVP EMEA-APAC) |
Regional manager |
BC Platforms (BCP) (Group) |
Switzerland |
| Dabrowski, Michael (Pelago Bioscience AB 201506 CEO) |
Chief Executive Officer (CEO) |
Pelago Bioscience AB |
Sweden |
| Dabrowski, Tomasz (Dentons 201412 Europe CEO) |
Chief Executive Officer (CEO) |
Dentons (Group) |
Switzerland |
| Dabu, Ferdinand (SGS 201011 Global Marketing Director Life Sciences Services R&D/QC) |
Sales Manager / Marketing Manager |
SGS (Group) |
Switzerland |
| Dachis, Jeffrey A. (Jeff) (Informed Data Systems 201909 CEO + Founder) |
Chief Executive Officer (CEO) |
Informed Data Systems Inc. |
United States (USA) |
| Dadlani, Manou (CosmosID 201601 CEO) |
Chief Executive Officer (CEO) |
CosmosID Inc. |
United States (USA) |
| Dadswell, Charles (Illumina 201604 SVP + General Counsel) |
General Counsel / Chief Legal Officer (CLO) |
Illumina (Group) |
United States (USA) |
| DaFonseca, Mark (Ambio Pharmaceuticals 202210 EVP Sales + Global BusDev at AmbioPharm before CoreRx) |
Business Development Manager / Strategy Manager |
Ambio Pharmaceuticals (Group) |
United States (USA) |
| Daglinger, Birgit (Ferring 201210 Managing Director of Ferring Arzneimittel GmbH) |
Managing Director |
Ferring (Paulsen Foundation) (Group) |
Germany |
| Dahiyat, Bassil (Xencor 200607 President + CEO) |
Chief Executive Officer (CEO) |
Xencor Inc. (Nasdaq: XNCR) |
United States (USA) |
| Dahlhauser, Eric B. (Insight Genetics 201201 CEO before Genetics Assays CEO) |
Chief Executive Officer (CEO) |
Insight Genetics Inc. |
United States (USA) |
| Dahlstroem, Christina (Epigenomics) |
n. a. |
Epigenomics (Group) |
Germany |
| Dahmen-Levison, Ursula (Aokin AG 201104 CEO) |
Chief Executive Officer (CEO) |
Aokin AG |
Germany |
| Dainese, Riccardo (Alithea Genomics 202205 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Alithea Genomics S.A. |
Switzerland |
| Dallas, Jayson (Aimmune Therapeutics 201806– CEO before Ultragenyx + Roche + Novartis + Pfizer + P&G Pharma) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
United States (USA) |
| Dalle Carbonare, Bruno H. |
n. a. |
University of Basel |
Switzerland |
| Dallmann, Isabel (Apogenix 200603) |
n. a. |
Apogenix AG |
Germany |
| Daly, David J. (Thrive Earlier Detection 201908– CEO before Illumina + Foundation Medicine + Life Technologies) |
Chief Executive Officer (CEO) |
Exact Sciences (Group) |
United States (USA) |
| Damgaard-Iversen, Karsten (Humedics 201705– CEO before Toshiba Europe + SonoCine + Fisher Imaging + Storz Medical) |
Chief Executive Officer (CEO) |
Humedics GmbH |
Germany |
| Daminger, Dieter (BioPark Regensburg 201104 Managing Director) |
Managing Director |
Regensburg (govt city) |
Germany |
| Damour, Bertrand (Pheon Therapeutics 202209– CEO before NBE Therapeutics + Synthena + OncoEthix + Egalet + GeneProt) |
Chief Executive Officer (CEO) |
Pheon Therapeutics (Group) |
United Kingdom (GB) |
| Dancer, Jane E. (F-Star 201205– COO before Cellzome 200801– VP BusDev before CAT) |
Chief Operating Officer (COO) |
Sino Biopharm (Group) |
United Kingdom (GB) |
| Dandekar, Thomas |
n. a. |
University of Würzburg |
Germany |
| Danforth, Peter (Wacker 202201 Business Development Manager at Wacker Biotech GmbH) |
General Manager (management) |
Wacker (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 13 14 15 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
